Reimagining Growth: A Market Beyond Mega-Caps

February 27, 2023

3 min read

Vinay Thapar, CFA| Co-Chief Investment Officer and Senior Research Analyst—US Growth Equities; Portfolio Manager—Global Healthcare

John H. Fogarty, CFA| Co-Chief Investment Officer—US Growth Equities

Broadening US Market Opens Wider Growth Opportunities

A mountain chart on the left shows the market capitalization of the Russell 1000 Growth Index, with the FAANGM stocks inset. Bar chart on the right shows profitability and sales growth of the Russell 1000 Growth Index with and without the FAANGM stocks, and without Apple.

Past performance does not guarantee future results.
*FAANGM includes Meta Platforms (Facebook), Amazon, Apple, Netflix, Alphabet Inc. (Google) and Microsoft.
†Where securities have been excluded from the index, the excluded weights were reallocated amongst the remaining holdings on a market-cap weighted basis.
Left display through December 31, 2022; right display as of February 17, 2023
Source: FactSet, FTSE Russell and AllianceBernstein (AB)

US growth stocks were hit hard in last year’s downturn, with the mega-caps accounting for nearly half of the market’s decline. Now, the changing contours of the market mean investors can capture a broader array of recovery candidates while incurring less benchmark risk.

Last year’s shake out of mega-cap US stocks is reshaping the market. The so-called FAANGM stocks—Meta Platforms (Facebook), Apple, Amazon, Netflix, Alphabet Inc. (Google) and Microsoft—dominated market performance for several years. At its peak in January 2022, the FAANGM cohort comprised 36% of the Russell 1000 Growth benchmark. By the end of last year, that group comprised 29% of the index (Display).

Bigger Pond for Growth Investors

To be sure, the aggregate weight of the largest companies is still above pre-pandemic levels. Yet when the market capitalization of stocks worth a combined $7 trillion falls by a few points, it opens the door for a wider array of stocks to contribute to market and portfolio returns. This means discerning investors have a bigger pond to fish in for companies with resilient businesses, solid profitability and attractive growth prospects that can perform well through challenging economic times.

Market data show that features like these can be found away from the mega-caps. For example, in mid-February, the Russell 1000 Growth’s return on assets—a key measure of profitability—was 16.2% and its sales growth was 9.6%. When you strip Apple out of the index, profitability declines, but growth actually increases. And when the entire FAANGM cohort is removed, profitability is still quite attractive and growth largely unchanged, in our view. In other words, we believe it’s possible to create a diversified portfolio of attractive US growth stocks today without making sacrifices or concentrating too heavily in the largest names.

Improved Conditions for Risk Budgeting

Of course, some mega-caps will retain dominant business positions and may continue to offer attractive investing opportunities. However, passive portfolios will be forced to own the entire cohort. We believe each company should be evaluated individually and held at positions appropriate to a portfolio’s investment philosophy and discipline. In an environment of structurally higher inflation and interest rates, increased selectivity is essential to identify those with robust long-term growth prospects.

By positioning beyond the mega-caps, portfolio managers can also improve their risk budgeting. A broader benchmark reduces the tracking error of portfolios with large underweights of mega-caps.

The moral of the story? Portfolios seeking to capture future market leadership don’t have to rely on yesterday’s champions to drive tomorrow’s returns.

The views expressed herein do not constitute research, investment advice or trade recommendations and do not necessarily represent the views of all AB portfolio-management teams. Views are subject to revision over time.

About the Authors

Vinay Thapar, CFA

Vinay Thapar is a Senior Vice President and Co-Chief Investment Officer for US Growth Equities and a Portfolio Manager for the Global Healthcare Strategy. He is also a Senior Research Analyst, responsible for covering global healthcare. Before joining the firm in 2011, Thapar spent three years at American Century Investments as a senior investment analyst responsible for healthcare. Prior to that, he worked for eight years at Bear Stearns in the Biotech Equity Research Group, most recently as an associate director. Thapar holds a BA in biology from New York University and is a CFA charterholder. Location: New York

John H. Fogarty, CFA

John H. Fogarty is a Senior Vice President and Co-Chief Investment Officer for US Growth Equities. He rejoined the firm in 2006 as a fundamental research analyst covering consumer-discretionary stocks in the US, having previously spent nearly three years as a hedge fund manager at Dialectic Capital Management and Vardon Partners. Fogarty began his career at AB in 1988, performing quantitative research, and joined the US Large Cap Growth team as a generalist and quantitative analyst in 1995. He became a portfolio manager in 1997. Fogarty holds a BA in history from Columbia University and is a CFA charterholder. Location: New York

Reimagining Growth: A Market Beyond Mega-Caps

Bigger Pond for Growth Investors

Improved Conditions for Risk Budgeting

More For You